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Abstract— Neuronal outputs are complex signals of dynam-
ically integrated excitatory and inhibitory components. De-
creased synaptic inhibition in a neuronal network increases 
excitability and multiple spiking in neurons. Synchronized 
multiple spiking among a neuronal population further gener-
ates rhythmic field potentials and this epileptiform activity can 
propagate in the brain and cause seizures. Pharmacological 
interventions that reduce rhythmicity of epileptiform activity 
may have antiepileptic potentials. We evaluated the Lempel-
Ziv (LZ) complexity for identifying rhythmicity in population 
spikes recorded in granule cells of the murine dentate gyrus in 
vitro. Blocking synaptic inhibition by the GABAA receptor 
antagonist, bicuculline, caused epileptiform population spikes, 
and we found that the LZ complexity of the signal was signifi-
cantly reduced. Moreover, the GABAB receptor agonist, baclo-
fen, reduced the amplitude of the epileptiform population 
spike and we found that it increased LZ complexity. The re-
sults show that LZ complexity is sensitive to pharmacological 
interventions that apparently alter rhythmicity of neuronal 
outputs by desynchronizing neuronal population firing. This 
novel approach in neuronal signal processing may be used to 
identify new antiepileptic targets.   
Keywords— Lempel-Ziv complexity, epileptiform activity, 
dentate gyrus, excitation, synaptic inhibition 
I. INTRODUCTION  
Epilepsy is one of the most common neurological disor-
ders affecting about 1% of the population. Paroxysmal neu-
ronal population firing of high amplitude and high rhyth-
micity is generated in the brain and the epileptiform activity 
propagates in synchrony causing various forms of seizures. 
This debilitating condition often requires lifelong treatment. 
However, causes of seizures are often undiagnosed in indi-
vidual patient. As treatments are limited to a small number 
of targets, seizures in as many as 30% patients are refracto-
ry to medication [1]. A full understanding of cellular events 
and molecular mechanisms that control the occurrence of 
epileptiform activity is therefore essential for developing 
more targeted therapeutic approaches. 
Increased excitability of neuronal circuits is thought to 
underlie generation of epileptiform activity. Decreased 
expression of the inhibitory neurotransmitter GABA (gam-
ma-aminobutyric acid) and reduced GABAergic synaptic 
inhibition are some of the major deficits found in patients 
and in preclinical animal models [2]. In brain tissue isolated 
in vitro, blocking GABAA receptors significantly reduces 
synaptic inhibition and neuronal firing pattern is changed 
from a single spike to repetitive firing following a brief 
stimulation of excitatory inputs [3]. The repetitive firing is 
often synchronized within a neuronal population and the 
resultant rhythmic signals have been predicted to enable 
widespread synchrony in the brain. Subsequently, pharma-
cological treatments that reduce rhythmicity of activities 
may have antiepileptic potentials [4].  
In this pilot work the rhythmicity of epileptiform data 
was studied with Lempel-Ziv (LZ) complexity, a non-linear 
method of symbolic sequence analysis. We examined popu-
lation spike (PS) waveforms recorded from granule cells in 
the dentate gyrus in vitro. Our previous results show that 
PSs with multiple spikes were induced using GABAA recep-
tor antagonist, bicuculline, and this epileptiform activity 
was reduced in amplitude by the GABAB receptor agonist, 
baclofen [3]. The hypothesis of this study was that LZ com-
plexity would highlight pharmacologically induced changes 
in rhythms in stimulus evoked PSs. 
II. MATERIAL AND METHODS 
A. Data collection 
The PSs were recorded from the soma of granule cells in 
the dentate gyrus [3]. Briefly, transverse sections of the 
dentate gyrus and the hippocampus were cut at 300 µm 
thickness using a vibratome. The use of wild-type mice was 
in accordance with the Animals in Scientific Procedures Act 
(1986) UK. The brain slices were kept in oxygenated (5% 
CO2 / 95% O2) artificial cerebrospinal fluid, which con-
tained (in mM) NaCl (123), Na2CO3 (25), glucose (10), KCl 
(3.7), CaCl2 (2.5), NaH2PO4 (1.4) and MgSO4 (1.2), and 
maintained at 31°C. Recordings of excitatory synaptic po-
tential and PSs were from a multi-electrode probe (MED-
P210A; MED64, Alpha MED Sciences, Osaka, Japan), 
which consists of 64 indium tin oxide and platinum black 
electrodes arranged in an 8 by 8 grid with an inter-electrode 
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distance of 100 µm. Electrical pulses (0.2 ms in duration) 
were delivered every 60 s to stimulate the excitatory inputs, 
the perforant pathway via one of the electrodes in the array. 
Stimulation, recording and analysis of extracellular poten-
tials were performed using the Mobius software (version 
0.3.7; Alpha MED Sciences, Osaka, Japan).  
PS waveforms displayed positively deflected field excita-
tory synaptic potential superimposed by a large negatively-
deflected spike when recorded in the baseline condition. An 
example of this is shown in Figure 1 (trace identified as B). 
Following 30 minutes of stable recording of baseline sig-
nals, GABAA receptor antagonist, (-)-bicuculline (Bic, 
10µM, Sigma-Aldrich, UK), GABAB receptor agonist, (±)-
baclofen (Bac, 10µM, Sigma-Aldrich, UK), and antagonist, 
CGP55845 (CGP, 1µM, Tocris Bioscience, UK) were ex-
amined by bath application for at least 15 minutes to 
achieve equilibrium. Example PS recordings under each 
treatment are shown in Figure 1. The PS after drugs wash-
ing out is also shown in Figure 1 (W). 
 
 
 
Fig. 1 Example set of PS recordings at baseline (B), and following treat-
ments with bicuculline (Bic), bicuculline and baclofen (Bic+Bac), 
bicuculline and CGP55845 (Bic+CGP), and after washing out drugs (W). 
The stimulus artifact is shown at the first 5ms of recording. 
B. Lempel-Ziv complexity 
LZ complexity is a non-linear method of symbolic se-
quence analysis. Originally suggested by Lempel and Ziv 
[5] for data compression, LZ complexity soon found its way 
for the analysis of complexity in short time series. There are 
several reasons for this. First of all, LZ complexity is a non-
parametric method, i.e. no input parameters have to be de-
fined for its computation. Complexity in the LZ algorithm is 
related to the number of distinct substrings and the rate of 
their recurrence along the given sequence [6]. Furthermore, 
it does not require long data segments to compute [7]. In 
addition, LZ complexity is model-independent and only the 
relevant changes between activity patterns that make a dif-
ference to the underlying system itself are considered, re-
gardless of the nature – deterministic chaos, stochastic pro-
cess, etc. – of the system itself [8]. When applying LZ 
complexity analysis, a particular model of system dynamics 
is not tested; data differences are examined on the basis of 
algorithmic or Kolmogorov’s complexity (length of the 
shortest description of a string in some fixed symbolic lan-
guage) [9]. 
These useful properties paved the way for the application 
of LZ complexity to biomedical signal processing. Bio-
medical signals are often of short length, contaminated by 
noise and non-stationary. These characteristics make the 
blind application of classic non-linear methods derived from 
chaos theory problematic. LZ complexity offers a fast and 
accurate estimation of complexity in Kolmogorov’s sense 
for biomedical signals. 
The LZ complexity algorithm involves converting the 
original time series into a discrete sequence of a finite num-
ber of symbols. In this study the median was used as the 
threshold Td in the sequence conversion, given that the me-
dian is robust to outliers [10]. A sequence P = s(1), s(2),, 
s(n) is created by comparing the samples from the original 
sampled signal x(i) with the threshold, with s(i) given by:  
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Once this coarse-grained sequence has been created from 
the original signal, P is scanned from left to right and the 
complexity counter c(n) is increased by one unit every time 
a new subsequence of consecutive characters is encoun-
tered. A detailed description of the complexity algorithm 
can be found in [8]. 
The complexity algorithm is dependent on the sequence 
length. For this reason, c(n) should be normalized. For a 
sequence of length n and an alphabet of  symbols (in the 
case of a binary conversion,  = 2), the upper bound of c(n) 
is given by [5]:  
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where n is a small quantity and n  0 (n  ). In general, 
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Therefore, c(n) can be normalized via b(n): 
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C(n) is then the normalized LZ complexity. Greater C(n) 
values correspond to more complexity in the data. 
C. Statistical analysis 
Normality of the LZ complexity results was evaluated us-
ing Lilliefors test. Treatment effects were compared using 
repeated-measures one-way ANOVA followed by Tukey’s 
multiple comparisons. Statistical significance was taken as 
p<0.05. All statistical analyses were performed using Prism 
5 (GraphPad Software Inc. La Jolla, CA 92037 USA). 
III. RESULTS 
LZ complexity was estimated from six datasets of PS 
waveforms recorded with a sampling frequency of 20 kHz 
under the 5 different conditions: baseline, bicuculline, 
bicuculline and baclofen, bicuculline and CGP55845, and 
after drugs washing out. Thirty minutes of stable recording 
was usually carried out before any drug treatment during the 
baseline period (B, Figure 1). To induce epileptiform activi-
ty, bicuculline (Bic, 10µM) was applied to the brain slice 
for 15 minutes (Bic, Figure 1). Multiple spiking PSs were 
recorded due to repetitive firing in individual neurons, re-
flecting increased excitability. Then, baclofen (10µM) was 
added to the bicuculline medium (Bic+Bac, Figure 1) to see 
if GABAB receptor activation can affect epileptiform activi-
ty. Significant reduction in the amplitude of late PSs was 
found [3], but whether the rhythm persisted or not was un-
clear. To determine whether the anti-epileptiform effect of 
baclofen is due to receptor activation, we also examined 
CGP55845 in the presence of bicuculline (Bic+CGP, Figure 
1), and an increase in late PSs was observed. Finally, wash-
out of both bicuculline and CGP55845 (W, Figure 1) re-
stored the PS to the single spike waveform at baseline. The 
PS waveforms at these conditions show distinct characteris-
tics in rhythm, so that LZ complexity analysis was per-
formed and results are shown in Table 1. The stimulus arti-
fact at 5ms of each recording was not included in the 
analysis. 
LZ complexity was significantly reduced in bicuculline-
treated PS waveforms in all data sets from the baseline 
(p<0.01, B vs. Bic, Table 1), potentially reflecting increased 
rhythmicity in epileptiform activity. Addition of baclofen to 
bicuculline increased LZ complexity values significantly 
(p<0.05, Bic vs. Bic+Bac, Table 1) to a level that is not 
different from the baseline (p>0.05, Bic+Bac vs. B, Table 
1). GABAB receptor activation therefore reduced rhythmici-
ty in the epileptiform activity. Blocking GABAB receptors 
with CGP55845, moreover, reduced the complexity 
(p<0.01, Bic+Bac vs. Bic+CGP, Table 1) back down again 
to a level similar to bicuculline alone (p>0.05, Bic+CGP vs. 
Bic, Table 1). It is also noted that the co-treatment of 
bicuculline and CGP55845 produced more consistently 
lower LZ complexity that is also significantly different from 
the baseline (p<0.001, Bic+CGP vs. B, Table 1) and wash-
out (p<0.001, Bic+CGP vs. W, Table 1). Finally, returning 
to drug-free medium effectively increased LZ complexity 
(p<0.001, Bic+CGP vs. W, and p<0.01, Bic vs. W, Table 1) 
to the level of the baseline (p>0.05, B vs. W, Table 1).  
Table 1 LZ complexity results for six datasets of PS waveforms under 
different pharmacological treatment conditions 
Set B Bic Bic+Bac Bic+CGP W 
1 0.1750 0.0255 0.1640 0.0292 0.2078 
2 0.1130 0.0693 0.0765 0.0838 0.1349 
3 0.1203 0.0365 0.0729 0.0328 0.0620 
4 0.2151 0.0401 0.2406 0.0547 0.2624 
5 0.1932 0.1567 0.1859 0.0911 0.1859 
6 0.2880 0.1349 0.2114 0.0875 0.2187 
Mean ± 
SD 
0.1841 ± 
0.0649 
0.0772 ± 
0.0555 
0.1586 ± 
0.0698 
0.0632 ± 
0.0281 
0.1786 ± 
0.0708 
B: baseline period before any treatment; Bic: treatment with 
bicuculline (10µM); Bic+Bac: co-application of bicuculline 
(10µM) and baclofen (10µM); Bic+CGP: co-application of 
bicuculline (10µM) and CGP55845 (1µM); W: washout of drugs. 
IV. DISCUSSION AND CONCLUSIONS  
The results show that LZ complexity of PS waveforms 
changes significantly following pharmacological treatments. 
Firstly, the LZ complexity algorithm has identified signifi-
cantly reduced complexity following bicuculline treatment 
compared to the baseline control waveform. The GABAA 
receptor antagonist, bicuculline, blocks synaptic inhibition 
that suppresses recurrent excitation and reduces excitability 
of neurons [2]. As a result, multiple spiking in burst occurs 
in neurons. Synchronization among a group of neurons 
gives rise to multiple spikes at regular intervals in the popu-
lation field potential and rhythmicity is increased. Con-
versely, the baseline PS waveforms with single spike show 
higher levels of complexity, as the signal is the result of 
complex integration of excitatory and inhibitory actions. 
Therefore, reduced LZ complexity is found in epileptiform 
activity associated with increased rhythmicity due to syn-
chronous multiple spiking in neurons. 
GABAB receptors are G-protein coupled receptors for the 
inhibitory neurotransmitter GABA. They mediate inhibitory 
actions in the brain by presynaptic inhibition of neurotrans-
mitters and postsynaptic inhibition of membrane excitability 
[11]. The receptor agonist, baclofen, has been reported to 
suppress epileptiform activity and seizures in patients and in 
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animal models of seizures, showing an antiepileptic action 
[12]. In the dentate gyrus, GABAB receptors are predomi-
nantly expressed on inhibitory pathways to modulate 
GABA release presynaptically, and on granule cells to regu-
late their excitability postsynaptically. When GABAA recep-
tors are blocked by bicuculline, the effect of baclofen on 
granule cells is more likely to be postsynaptic, and this 
reduced amplitude of the epileptiform activity. Now we 
show that LZ complexity is significantly increased by bac-
lofen, so that rhythmicity in the epileptiform activity is 
reduced, indicating desynchronization between neurons. 
GABAB receptor activation in the dentate gyrus is therefore 
potentially antiepileptic by reducing rhythmicity in 
epileptiform activity.  
Accordingly, GABAB receptor antagonist, CGP55845, 
significantly reduced LZ complexity to the level of 
bicuculline, opposite to the effect of baclofen. Reduction in 
rhythmicity is therefore specific to activation of GABAB 
receptors. Moreover, the co-treatment of bicuculline and 
CGP55845 consistently produced lower LZ complexity, 
indicating additional rhythmic effect of GABAB receptor 
blockade. 
Finally, washing out of both bicuculline and CGP55845 
restored both the baseline waveform of PSs and LZ com-
plexity. The LZ complexity analysis can therefore distin-
guish the different pharmacological treatments, indicating 
its potential for measuring rhythmicity in epileptiform activ-
ity. 
To the best of our knowledge, this is the first time LZ 
complexity has been successfully applied to the detection of 
significant changes induced pharmacologically in short, 
stimulus-evoked traces with limited number of repetitive 
cycles. It is, however, noted that the LZ complexity values 
obtained were scattered with considerable overlap between 
treatments. For example, some epileptiform traces have 
higher complexity values than baseline traces in other sets. 
However, within each dataset the trend is consistent. Further 
investigation is required to look into the potentially con-
founding characteristics in these traces. In addition, signal 
averaging may be applied to further eliminate contamina-
tion by rhythmic noises. Furthermore, although results are 
promising, the sample size was small. As a result, our find-
ings are preliminary and require replication in a larger data-
base of PS waveforms before any conclusion can be made 
of its potential impact. However, our findings show that the 
non-linear analysis of stimulus evoked-traces identifies 
pharmacologically induced changes. 
In summary, we found that LZ complexity was signifi-
cantly reduced in bicuculline-induced epileptiform activity 
and baclofen restored the reduced LZ complexity to the 
control level. LZ complexity may therefore be used as a 
novel analysis to measure rhythmicity in epileptiform ac-
tivity. Caution should be applied due to the small sample 
size. 
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